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del(12)(p12) G-banding - Courtesy Diane H. Norback, Eric B. Johnson, and Sara Morrison-Delap, UW Cytogenetic Services. 
Clinics and pathology 
Disease 
Acute lyphocytic leukemia (ALL). 
Phenotype/cell stem origin 
Lack of specificity for particular immunophenotype, 
although more stem origin frequent in B-lineage cases. 
Epidemiology 
Approximately 10-15% of pediatric ALL cases, and 5% 
of adult ALL. 
Prognosis 
Recent data indicate no difference in overall outcome 
between childhood ALL cases with versus without 12p 
abnormalities, although there was an improved 
outcome for pseudodiploid patients with versus without 
a cytogenetic 12p abnormality; although a dic(9;12) has 
been reported to be associated with an excellent 
outcome, in a recent study, there was no difference in 
outcome between those patients with a dic(9;12) versus 
patients lacking an abnormal 12p. 
Cytogenetics 
Cytogenetics morphological 
Various aberrations result in an abnormal 12p; these 
include morphological balanced translocations with 
12p breakpoints, del(12p), add(12p), monosomy 12, 
der(12)t(V;12)(V;p), and dic(V;12)(V;p); an abnormal 
12p usually occurs as part of a more complex 
karyotype, and occurs as the sole aberration in less than 
20% of cases with an abnormal 12p; in greater than 
10% of cases both 12p homologues are abnormal; few 
cases with an abnormal 12p have more than 50 
chromosomes. 
Additional anomalies 
del(6q), del(13q) or monosomy 13, acquired +21; few 
recurring anomalies. 
Genes involved and proteins 
Note 
Approximately half of patients with an abnormal 12p 
have a rearranged TEL gene. 
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TEL proteins belong to the ETS family transcription 
factors; important in the vitelline angiogenesis and in 
the bone marrow hematopoiesis. 
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